{"product_id":"cst-6441s","title":"CST,  6441S, SignalSilence® Bcl-2 siRNA I","description":"siRNA for studying Bcl-2 in the research area.\n\n\u003cb\u003eProduct Usage Information\u003c\/b\u003e\nCST recommends transfection with 100 nM SignalSilence ® Bcl-2 siRNA I 48 to 72 hours prior to cell lysis. For transfection procedure, follow protocol provided by the transfection reagent manufacturer. Please feel free to contact CST with any questions on use. Each vial contains the equivalent of 100 transfections, which corresponds to a final siRNA concentration of 100 nM per transfection in a 24-well plate with a total volume of 300 μl per well.\n\u003cb\u003eStorage\u003c\/b\u003e\nSignalSilence ® siRNA is supplied in RNAse-free water. Aliquot and store at -20ºC.\n\u003cb\u003eBackground\u003c\/b\u003e\nBcl-2 exerts a survival function in response to a wide range of apoptotic stimuli through inhibition of mitochondrial cytochrome c release (1). It has been implicated in modulating mitochondrial calcium homeostasis and proton flux (2). Several phosphorylation sites have been identified within Bcl-2, including Thr56, Ser70, Thr74, and Ser87 (3). It has been suggested that these phosphorylation sites may be targets of the ASK1\/MKK7\/JNK1 pathway and that phosphorylation of Bcl-2 may be a marker for mitotic events (4,5). Mutation of Bcl-2 at Thr56 or Ser87 inhibits its anti-apoptotic activity during glucocorticoid-induced apoptosis of T lymphocytes (6). Interleukin-3 and JNK-induced Bcl-2 phosphorylation at Ser70 may be required for its enhanced anti-apoptotic functions (7). Silencing Bcl-2 expression by RNA interference induces p53 dependent apoptosis (8).\n\n\u003cb\u003eSpecification\u003c\/b\u003e\n\nREACTIVITY: H","brand":"CST","offers":[{"title":"Default Title","offer_id":46800789930153,"sku":"6441S","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/cst-6441s","provider":"Iright","version":"1.0","type":"link"}